Literature DB >> 19475415

Clinical review of corneal ulcers resulting in evisceration and enucleation in elderly population.

Marios Constantinou1, Vishal Jhanji, Lingwei William Tao, Rasik B Vajpayee.   

Abstract

PURPOSE: To identify the associated factors and study the clinical and microbiological characteristics of corneal ulcers resulting in evisceration and enucleation in elderly patients in a tertiary care hospital.
METHODS: A review of all patients who required evisceration or enucleation due to microbial keratitis at the Royal Victorian Eye and Ear Hospital, Melbourne, Australia between July 1998 and November 2007 was performed. Of these, patients more than 60 years of age were included in the study for analysis.
RESULTS: Forty-seven patients with microbial keratitis were included in the study. The mean age of patients was 81 +/- 9.39 years. Major ocular factors associated were glaucoma (49%), persistent corneal epithelial defect (38%) and use of corticosteroid eye drops (23%). Most common associated systemic factor was rheumatoid arthritis (36%). The indications for evisceration or enucleation were extensive non-healing microbial keratitis (22/47) and corneal perforation secondary to microbial keratitis (17/47). Pseudomonas aeruginosa was the most common pathogen, present in 15 patients, and more than 45% of the strains tested were resistant to chloramphenicol.
CONCLUSIONS: Corneal ulcers that result in the loss of eye in elderly population are frequently associated with glaucoma and persistent epithelial defects. The majority of these cases have non-healing microbial keratitis caused by Pseudomonas aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475415     DOI: 10.1007/s00417-009-1111-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  22 in total

1.  Microbial keratitis: what's the preferred initial therapy? View 2: Empirical fluoroquinolone therapy is sufficient initial treatment.

Authors:  N Morlet; M Daniell
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

2.  Moraxella keratitis: predisposing factors and clinical review of 95 cases.

Authors:  S Das; M Constantinou; M Daniell; H R Taylor
Journal:  Br J Ophthalmol       Date:  2006-07-06       Impact factor: 4.638

3.  Microbial keratitis predisposing factors and morbidity.

Authors:  Lisa Keay; Katie Edwards; Thomas Naduvilath; Hugh R Taylor; Grant R Snibson; Kevin Forde; Fiona Stapleton
Journal:  Ophthalmology       Date:  2005-12-19       Impact factor: 12.079

4.  Factors influencing predilection and outcome in bacterial keratitis.

Authors:  O G Gudmundsson; L D Ormerod; K R Kenyon; R J Glynn; A S Baker; J Haaf; S Lubars; M B Abelson; S A Boruchoff; C S Foster
Journal:  Cornea       Date:  1989       Impact factor: 2.651

5.  Causes and management of bacterial keratitis in the elderly.

Authors:  L D Ormerod
Journal:  Can J Ophthalmol       Date:  1989-04       Impact factor: 1.882

6.  Microbial keratitis resulting in loss of the eye.

Authors:  C S Cruz; E J Cohen; C J Rapuano; P R Laibson
Journal:  Ophthalmic Surg Lasers       Date:  1998-10

7.  Risk factors for perforation in microbial corneal ulcers in north India.

Authors:  J S Titiyal; S Negi; A Anand; R Tandon; N Sharma; R B Vajpayee
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

8.  Age-related risk factors, culture outcomes, and prognosis in patients admitted with infectious keratitis to two Dutch tertiary referral centers.

Authors:  Ivanka J van der Meulen; Jeroen van Rooij; Carla P Nieuwendaal; Hugo Van Cleijnenbreugel; Annette J Geerards; Lies Remeijer
Journal:  Cornea       Date:  2008-06       Impact factor: 2.651

9.  Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases.

Authors:  T Bourcier; F Thomas; V Borderie; C Chaumeil; L Laroche
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

10.  Clinical outcomes of keratitis.

Authors:  Matthew D Green; Andrew J G Apel; Thomas Naduvilath; Fiona J Stapleton
Journal:  Clin Exp Ophthalmol       Date:  2007-07       Impact factor: 4.207

View more
  8 in total

1.  The impact of age on the physical and cellular properties of the human limbal stem cell niche.

Authors:  M Notara; A J Shortt; A R O'Callaghan; J T Daniels
Journal:  Age (Dordr)       Date:  2012-01-15

2.  Phage display against corneal epithelial cells produced bioactive peptides that inhibit Aspergillus adhesion to the corneas.

Authors:  Ge Zhao; Siyuan Li; Wei Zhao; Kun He; Haijie Xi; Weihua Li; Qingjun Zhou; Yiqiang Wang
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

3.  Effects of diabetic keratopathy on corneal optical density, central corneal thickness, and corneal endothelial cell counts.

Authors:  Feng Gao; Tao Lin; Yingzhe Pan
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

Review 4.  Incidence of and risk factors for secondary ocular hypertension in moderate to severe infectious ulcerative keratitis.

Authors:  Darin Sakiyalak; Yuwared Chattagoon
Journal:  Clin Ophthalmol       Date:  2018-10-24

Review 5.  Repair Process Impairment by Pseudomonas aeruginosa in Epithelial Tissues: Major Features and Potential Therapeutic Avenues.

Authors:  Manon Ruffin; Emmanuelle Brochiero
Journal:  Front Cell Infect Microbiol       Date:  2019-05-31       Impact factor: 5.293

6.  Clinical Review of Microbial Corneal Ulcers Resulting in Enucleation and Evisceration in a Tertiary Eye Care Center in Hungary.

Authors:  Gábor Tóth; Milán Tamás Pluzsik; Gábor László Sándor; Orsolya Németh; Olga Lukáts; Zoltán Zsolt Nagy; Nóra Szentmáry
Journal:  J Ophthalmol       Date:  2020-05-18       Impact factor: 1.909

7.  Pathogens and Antibiotic Susceptibilities of Global Bacterial Keratitis: A Meta-Analysis.

Authors:  Zijun Zhang; Kai Cao; Jiamin Liu; Zhenyu Wei; Xizhan Xu; Qingfeng Liang
Journal:  Antibiotics (Basel)       Date:  2022-02-12

8.  Profile of Microbial Keratitis.

Authors:  James Lim Wen Siang; Ong Wu Zhuan; Ngio Yi Chen; Ng Sok Lin
Journal:  Cureus       Date:  2021-12-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.